Press Releases

PRESS RELEASES - year 2025

Press Release | 01 Aug 2025

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the Press Release of the Company for the First Quarter ended June 30, 2025….

Press Release | 15 May, 2025

Alivus Life Sciences Delivers Strong Q4FY25 Performance with 21% YoY Revenue Growth EBITDA Margins at 32.1% YoY…

Press Release | 23 Jan, 2025

Alivus Life Sciences Reports Strong Q3FY25 Results, Delivers 12%…

Press Release | 18 Jan, 2025

Glenmark Life Sciences rebrands as Alivus Life Sciences…

PRESS RELEASES - year 2024

Press Release | 24 Oct, 2024

Glenmark Life Sciences reports revenue of Rs. 5,069 Mn for Q2FY25, Gross margins of 55.6%, up…

Press Release | 25 July, 2024

Glenmark Life Sciences reports revenue growth of 9.7% QoQ for Q1FY25, EBITDA margins of 28%, up…

Press Release | 25 April, 2024

Glenmark Life Sciences reports revenue growth of 5.6%, EBITDA margins of 30.1% in FY24

Press Release | 12 March, 2024

Nirma Limited acquires majority stake in Glenmark Life Sciences

Press Release | 23 Jan, 2024

Glenmark Life Sciences reports quality revenue growth of 5.9% YoY Delivers robust EBITDA growth

Press Release | 19 Jan, 2024

Glenmark Life Sciences announces another CDMO deal

year 2023

Press Release | 20 Oct, 2023

Glenmark Life Sciences Strong Growth Momentum Continues, Revenue Surges 17% YoY…

Press Release | 21 July, 2023

Glenmark Life Sciences maintains strong growth momentum, reports robust 25% EBITDA growth in…

Press Release | 27 April, 2023

Glenmark Life Sciences sustains strong growth momentum in Q4FY23

year 2022

Press Release | 27 January, 2023

Revenue growth of 6% QoQ Strong growth in India, Europe and LATAM with recovery in US business

Press Release | 21 Oct, 2022

Revenue growth of 4% QoQ Regulated markets led the growth

Press Release | 04 Aug, 2022

PAT growth of 7.7% YoY for Q1 FY23 CVS and CNS therapies lead the growth of the generic API

Press Release | 20 April, 2022

Glenmark Life Sciences reports revenue growth of 10% YoY for Q4 FY22; 12.6% for the full year, FY22

Press Release | 8 February, 2022

Glenmark Life Sciences reports revenue growth of 4.5% and PAT growth of 11.1% YoY for Q3 FY22

year 2021

Press Release | 10 November, 2021

Glenmark Life Sciences reports revenue growth of 7.9% and PAT growth of 59.0% YoY for Q2 FY22…

Press Release | 13 August, 2021

Glenmark Life Sciences reports revenue growth of 32.2% and PAT growth of 24.5% YoY for Q1 FY22

year 2019

Press Trust of India | 07 May, 2019

Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its…